Literature DB >> 18703137

The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.

S Taetz1, N Nafee, J Beisner, K Piotrowska, C Baldes, T E Mürdter, H Huwer, M Schneider, U F Schaefer, U Klotz, C-M Lehr.   

Abstract

Tailorable cationic chitosan/PLGA nanoparticles (CPNP) were used for the delivery of an antisense 2'-O-methyl-RNA (2OMR) directed against RNA template of human telomerase. Here, we describe the influence of the chitosan content on binding efficiency, complex stability, uptake in different human lung cell types and finally demonstrate the efficacy of this nanoplex system. CPNPs were prepared by the emulsion-solvent evaporation method using different amounts of chitosan and purified by preparative size exclusion chromatography. The characterization by photon correlation spectroscopy and zeta potential measurements showed a small increase in size and an increase of zeta potential with increasing amounts of chitosan. Binding efficiency and complex stability with 2OMR was high in water and correlated well with the chitosan content of particles but was weak in physiologically relevant media (PBS and RPMI cell culture medium). However, flow cytometry analysis showed that the uptake of 2OMR into A549 lung cancer cells was considerably higher in combination with nanoparticles and dependent on the amount of chitosan when compared to 2OMR alone. Confocal laser scanning microscopy revealed that the uptake into A549 cells is mediated via complexes of 2OMR and chitosan/PLGA nanoparticles despite the weak binding in cell culture medium. The nanoparticles were well tolerated and efficient in inhibiting telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703137     DOI: 10.1016/j.ejpb.2008.07.011

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

1.  Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.

Authors:  Tianzhi Yang; Divine Nyiawung; Alexandra Silber; Jiukuan Hao; Leanne Lai; Shuhua Bai
Journal:  AAPS PharmSciTech       Date:  2012-09-28       Impact factor: 3.246

2.  A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.

Authors:  Isabelle Serr; Martin G Scherm; Adam M Zahm; Jonathan Schug; Victoria K Flynn; Markus Hippich; Stefanie Kälin; Maike Becker; Peter Achenbach; Alexei Nikolaev; Katharina Gerlach; Nicole Liebsch; Brigitta Loretz; Claus-Michael Lehr; Benedikt Kirchner; Melanie Spornraft; Bettina Haase; James Segars; Christoph Küper; Ralf Palmisano; Ari Waisman; Richard A Willis; Wan-Uk Kim; Benno Weigmann; Klaus H Kaestner; Anette-Gabriele Ziegler; Carolin Daniel
Journal:  Sci Transl Med       Date:  2018-01-03       Impact factor: 17.956

3.  The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.

Authors:  Xudong Yuan; Bruhal A Shah; Naimesh K Kotadia; Jian Li; Hua Gu; Zhiqian Wu
Journal:  Pharm Res       Date:  2010-03-23       Impact factor: 4.200

Review 4.  Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Authors:  Chiranjeevi Peetla; Andrew Stine; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

5.  Therapeutic nanosystems for oncology nanomedicine.

Authors:  A S Gonçalves; A S Macedo; E B Souto
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

6.  Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers.

Authors:  Mariam Zewail; Noha Nafee; Maged W Helmy; Nabila Boraie
Journal:  Drug Deliv Transl Res       Date:  2021-05-19       Impact factor: 4.617

Review 7.  Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.

Authors:  Narsireddy Amreddy; Anish Babu; Ranganayaki Muralidharan; Anupama Munshi; Rajagopal Ramesh
Journal:  Top Curr Chem (Cham)       Date:  2017-03-13

8.  Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis.

Authors:  Nusaiba K Al-Nemrawi; Nid''A H Alshraiedeh; Aref L Zayed; Bashar M Altaani
Journal:  Pharmaceuticals (Basel)       Date:  2018-03-08

Review 9.  Nanomedicine in pulmonary delivery.

Authors:  Heidi M Mansour; Yun-Seok Rhee; Xiao Wu
Journal:  Int J Nanomedicine       Date:  2009-12-29

10.  Utilization of Cladophora glomerata extract nanoparticles as eco-nematicide and enhancing the defense responses of tomato plants infected by Meloidogyne javanica.

Authors:  Rehab Y Ghareeb; Hanan Alfy; Antwan A Fahmy; Hayssam M Ali; Nader R Abdelsalam
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.